The agreement for bamlanivimab, which was the first Lilly antibody treatment to receive emergency authorization, now includes etesevimab. Using a combination of the two antibody therapies is more effective against some of the new virus variants that have …
See Original Article

Mastercard Inc. is rolling out a tool that will allow consumers to gauge how their spending impacts the environment in what the company says is its latest attempt to become more sustainable in its business practices. The payments giant is working with …
See Original Article

Zentalis Pharmaceuticals Inc. said it has entered into a clinical collaboration agreement with GlaxoSmithKline PLC. Zentalis said it will evaluate the combination of ZN-c3, an oral WEE1 inhibitor product candidate, and Zejula niraparib, GlaxoSmithKline’s …
See Original Article

Ameriprise noted that the all-cash transaction adds $124 billion of AUM in Europe and is currently expected to close in the fourth quarter of 2021. Ameriprise expects that the transaction will be accretive in 2023 and …
See Original Article

Marketed Breast Cancer Drugs Dosage, Patent & Pricing; Drugs Classification by Class: SERD, EGFR, Mitotic Inhibitors, CDK 4/6, Hormonal, PARP Inhibitors & More; Insight on Ongoing Research & Collaborations …
See Original Article